![Marek Mlotek-Kucharczyk](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marek Mlotek-Kucharczyk
Director/Board Member at KCR CRO GmbH
Profile
Marek Mlotek-Kucharczyk is a member of the supervisory board at KCR CRO GmbH.
He is a graduate of the Warsaw School of Economics.
Marek Mlotek-Kucharczyk active positions
Companies | Position | Start |
---|---|---|
KCR CRO GmbH
![]() KCR CRO GmbH Miscellaneous Commercial ServicesCommercial Services KCR SA provides clinical research services. It operates as a European contract research organization and strategic solutions provider for companies who are looking for a reliable alternative to global contract research organizations. The firm’s services include clinical trial, functional service provision, and late phase studies. It offers clinical project management, clinical monitoring, site management, feasibility studies, regulatory affairs, site start-up and contracting, biometrics and data management, quality assurance, cross-functional sourcing model, functional sourcing model, post-authorization efficacy study, post-authorization safety study, pricing and market access research, and case control study. The company was founded by Marek Kiecana in 1997 and is headquartered in Berlin, Germany. | Director/Board Member | - |
Training of Marek Mlotek-Kucharczyk
Warsaw School of Economics | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
KCR CRO GmbH
![]() KCR CRO GmbH Miscellaneous Commercial ServicesCommercial Services KCR SA provides clinical research services. It operates as a European contract research organization and strategic solutions provider for companies who are looking for a reliable alternative to global contract research organizations. The firm’s services include clinical trial, functional service provision, and late phase studies. It offers clinical project management, clinical monitoring, site management, feasibility studies, regulatory affairs, site start-up and contracting, biometrics and data management, quality assurance, cross-functional sourcing model, functional sourcing model, post-authorization efficacy study, post-authorization safety study, pricing and market access research, and case control study. The company was founded by Marek Kiecana in 1997 and is headquartered in Berlin, Germany. | Commercial Services |
- Stock Market
- Insiders
- Marek Mlotek-Kucharczyk